The Bidens have convened a diverse board and staff with the goal of continuing efforts to accelerate research and development begun under the Cancer Moonshot Initiative.
The agency hopes to gain data on the efficacy of BRAF targeted drugs used in sequence, and how physicians implement treatments compared to how the drugs are labelled.
Brigham & Women's Ravi Parikh coauthored a recent NEJM commentary calling for a Precision Delivery Initiative to supplement the Precision Medicine Initiative.
A new TGen analysis has unraveled breast cancer mutational patterns specific to black women that could help improve outcomes and reduce recurrence.
In 19,000 cases reported so far, researchers have gleaned data that enhances understanding of the spectrum of cancer mutations and supports the rationale of ongoing basket trial initiatives.
Codexis has been using its CodeEvolver platform to engineer high-performance enzymes for next-generation sequencing and PCR for in vitro diagnostics.
The new fund aims to advance data-driven innovations by investing in academic research on and the commercialization of genomic and other technologies.
A trio of academics urges for medical data donation at the Conversation.
The company, which is working on its own genetic test, provides customers with nutrition and lifestyle recommendations based on their genotyping profiles.
The Genomics Evidence Neoplasia Information Exchange aims to provide insights through the analysis of data from tens if not hundreds of thousands of patient results.
CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.
Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.
Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.
In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.